Evidence map›Paper›PMID 42095107›Full record

ArticleRSC advances2026

Evaluation of a GDNF-eluting nanofibrous PCL conduit in a mouse model of peripheral nerve injury.

Louis D V Johnson, Holly N Gregory, James B Phillips, Sara Memarpour Hobbi, Fiona M Boissonade, Frederik Claeyssens

Abstract read
In one paragraph

Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Louis D V JohnsonKroto Research Institute, School of Chemical, Materials and Biological Engineering, University of Sheffield Broad Lane Sheffield S3 7HQ UK f.claeyssens@sheffield.ac.uk.ORCID https://orcid.org/0000-0001-7590-2154
Holly N GregoryDepartment of Pharmacology, UCL School of Pharmacy London UK.ORCID https://orcid.org/0000-0002-2243-8201
James B PhillipsDepartment of Pharmacology, UCL School of Pharmacy London UK.ORCID https://orcid.org/0000-0001-8117-3074
Sara Memarpour HobbiSchool of Clinical Dentistry, University of Sheffield Claremont Crescent Sheffield S10 2TN UK.
Fiona M BoissonadeSchool of Clinical Dentistry, University of Sheffield Claremont Crescent Sheffield S10 2TN UK.
Frederik ClaeyssensKroto Research Institute, School of Chemical, Materials and Biological Engineering, University of Sheffield Broad Lane Sheffield S3 7HQ UK f.claeyssens@sheffield.ac.uk.ORCID https://orcid.org/0000-0002-1030-939X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe, gap-type peripheral nerve injuries often require surgical intervention in the form of a nerve autograft or synthetic nerve guidance scaffold to promote axonal regeneration and functional recovery. In this study, nerve guidance conduits (NGCs) were fabricated from aligned polycaprolactone (PCL) nanofibres with or without encapsulated glial cell line-derived neurotrophic factor (GDNF), and a fibrin sealant-based hydrogel. These constructs were evaluated in a murine sciatic nerve transection model using Thy1-YFP-H mice, allowing regenerating axons to be visualised in transverse sections throughout the constructs. Both PCL + GDNF and PCL-only conduits facilitated Schwann cell migration and successful axonal regeneration across the site of injury. Nerve autografts, the positive control, demonstrated the highest regenerating axon count in the distal stump, although statistical significance was not observed between groups. These results demonstrate that NGCs fabricated using aligned PCL nanofibres reliably facilitate nerve regeneration across nerve gaps to a degree, but require further investigation for application in peripheral nerve repair. Future studies that optimise growth factor delivery and conduit design would be beneficial to improve regenerative outcomes.

Identifiers

PMID42095107
PMCPMC13141687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.